- Home
- PSNY vs VCEL Comparison
PSNY vs VCEL Comparison
Compare PSNY & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSNY | VCEL |
|---|---|---|
| Founded | 2017 | 1989 |
| Country | Sweden | United States |
| Employees | 1686 | N/A |
| Industry | Auto Manufacturing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | PSNY | VCEL |
|---|---|---|
| Price | $18.81 | $44.54 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $15.00 | ★ $57.75 |
| AVG Volume (30 Days) | 126.2K | ★ 714.6K |
| Earning Date | 04-17-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $276,259,000.00 |
| Revenue This Year | $31.06 | $19.40 |
| Revenue Next Year | $47.98 | $18.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.45 |
| 52 Week Low | $0.50 | $28.95 |
| 52 Week High | $23.75 | $46.62 |
Technical Indicators
Market Signals| Indicator | PSNY | VCEL |
|---|---|---|
| Relative Strength Index (RSI) | 43.36 | 73.47 |
| Support Level | $18.29 | $32.47 |
| Resistance Level | $19.00 | N/A |
| Average True Range (ATR) | 1.39 | 1.73 |
| MACD | -0.24 | 0.68 |
| Stochastic Oscillator | 44.21 | 80.63 |
Price Performance
Historical ComparisonAbout PSNY Polestar Automotive Holding UK PLC ADS
Polestar Automotive Holding UK PLC is a pure play, premium electric car brand, designing performance cars engineered to excite consumers and drive change. It believes that it defines market standards in design, innovation and sustainability. It is determined to improve society by accelerating the shift to sustainable mobility. The company conducts its business as one operating segment with primary commercial operations in Europe, North America, Asia Pacific and various importer markets. The company generates majority of revenue from United Kingdom.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.